lutetium has been researched along with Neutropenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boerman, OC; Boers-Sonderen, MJ; Desar, IM; Langenhuijsen, JF; Mulder, SF; Mulders, PF; Muselaers, CH; Oosterwijk, E; Oyen, WJ; Stillebroer, AB; van Herpen, CM; van Oostenbrugge, TJ | 1 |
1 trial(s) available for lutetium and Neutropenia
Article | Year |
---|---|
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Carbonic Anhydrase IX; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Kidney Neoplasms; Lutetium; Neutropenia; Non-Randomized Controlled Trials as Topic; Radioimmunotherapy; Radioisotopes; Retreatment; Thrombocytopenia | 2016 |